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BACKGROUND/PURPOSE: Rotavirus is a major causative agent of pediatric gastroenteritis through-
out the world. However, other viruses such as norovirus also play an important role, but have seldom been 
studied in Taipei, Taiwan. The aim of this study was to survey the prevalence and clinical manifestations 
of different types of viral gastroenteritis in Taipei, focusing especially on the disease burden of norovirus.
METHODS: Between November 2004 and April 2005, stool samples were collected from hospitalized 
pediatric patients with a diagnosis of acute gastroenteritis. Clinical manifestations, laboratory data, and 
hospitalization course of the patients were all analyzed. Stool cultures for bacteria and rotavirus antigens 
were performed. All samples were tested for norovirus, enteric adenovirus, and astrovirus using enzyme-
linked immunosorbent assays.
RESULTS: A total of 75 stool specimens were collected during the 6-month period. Fifteen (20.0%) were 
positive for norovirus (3 genogroup I and 12 genogroup II). Three (4.0%) were positive for enteric adeno-
virus, and one (1.3%) for astrovirus. Nine (12.0%) patients had positive rotavirus antigen tests. Bacterial 
pathogens were found in 12 patients (16.0%), including seven cases of Salmonella, and five of Campylobacter. 
The patients with norovirus gastroenteritis were aged between 1.5–7.5 years old (median 20 months old). 
Fever was found in six patients (40.0%), and bloody, mucoid stools in three (20.0%). The mean hospitaliza-
tion time was 3.3 days. None of them had complications.
CONCLUSION: During the study period, norovirus was the most common pathogen causing hospital-
ized pediatric gastroenteritis in our hospital. Genogroup II was the predominant type (80.0%). Clinicians 
in Taipei should, therefore, be aware of the emergence of norovirus infections.
KEYWORDS: child, gastroenteritis, norovirus, Norwalk-like virus, rotavirus
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Introduction
Rotavirus is regarded as the most prevalent causative virus 
in pediatric gastroenteritis throughout the world.1 Several 
studies have revealed that rotavirus is also one of the leading 
pathogens in Taiwan.2–4 Other viruses such as norovirus, 
adenovirus, and astrovirus also play important roles, but 
there are only a few related studies in Northern Taiwan.3–6 
Norovirus, also known as Norwalk-like virus, is classified 
in a separate genus of Caliciviridae, and three genogroups of 
norovirus have been identified in humans. The transmis-
sion of norovirus is by direct person-to-person contact, or 
through contaminated food or water. More and more 
studies have reported that the prevalence of norovirus is 
higher than expected.4–8 Norovirus is associated with several 
large outbreaks, especially at respiratory care units and 
nursing homes.8–10 The aim of this study was to survey the 
prevalence and clinical manifestations of the different types 
of viral gastroenteritis in Taipei between November 2004 
and April 2005. We also tried to find out the genogroups 
of norovirus circulating around Taipei, and the specific 
clinical presentations associated with norovirus infection.
Methods
Study population
A prospective study was conducted at Mackay Memorial 
Hospital, which is a tertiary referral hospital in Taipei, Taiwan, 
to analyze the pathogens involved in pediatric gastroen-
teritis between November 2004 and April 2005. This study 
was approved by the Institutional Review Board (MMH-I-
S-372) of Mackay Memorial Hospital.
Stool samples for viral studies were collected from 
hospitalized pediatric patients with a diagnosis of acute 
gastroenteritis (ICD-9-CM code: 558.9). The decision to 
admit to hospital was based on the physician’s judgment. 
Most of the patients had severe diarrhea with dehydration. 
Patients with critical conditions, underlying bowel diseases, 
or those on antibiotic before admission, were excluded.
Two kinds of rotavirus vaccine, RotaTeq (Merck & Co., 
Whitehouse station, NJ, USA) and Rotarix (GlaxoSmithKine 
Biologicals, Rixensart, Belgium), were not available at 
Mackay Memorial Hospital during the study period, but 
some rotavirus vaccine trials were proceeding. Those patients 
who had received a trial rotavirus vaccine were also excluded 
from the study, as were specimens of inadequate quantity, 
and those with mixed infections.
Laboratory analysis
After admission, cultures for stool bacteria and enteric vi-
ruses were performed. For the bacteria cultures we used 
rectal swabs for stool sampling, and each stool sample was 
cultured using the streak plate method on culture media 
with Hektoen enteric, Salmonella-Shigella and Campylobacter 
agars. If no pathogen was isolated after 72 hours, the re-
sult was deemed negative. For the viral tests, specimens were 
collected and stored at −20ºC before analysis. Stool rotavirus 
was tested for using specific commercial enzyme immu-
noassay kits (Premier™ Rotaclone kit; Meridian Diagnostics, 
Cincinnati, OH, USA).11 All samples were tested in duplicate 
for norovirus, enteric adenovirus, and astrovirus using the 
IDEIA™ NLV EIA kit (Norwalk-like virus), code no. K6043 
(DakoCytomation Ltd., Ely, United Kingdom).12 Each 
sample was added to microwells, and incubated simulta-
neously with a norovirus specific genogroup I, or geno-
group II, polyclonal antibody according to the manufacturer’s 
instructions. The presence of specifically bound enzyme-
labeled antibody in the wells resulted in a color change.
Clinical comparison
Clinical manifestations, laboratory data, and hospitalization 
courses were analyzed. Mucoid, or blood-tinged stools were 
recorded as positive in character. Complete blood counts, 
C-reactive protein (CRP) levels, and electrolytes were com-
pared between the different pathogens. In addition, the age 
of admission was divided into four groups: < 6 months old; 
6–24 months old; 25–60 months old; and > 60 months old. 
The prevalence of the different pathogens within each age 
group was then compared.
The clinical presentations of the most common path-
ogens, i.e. norovirus and rotavirus, were then subjected to 
detailed comparison.
Statistical analysis
To compare the clinical manifestations and laboratory tests 
for the different pathogens, we used SPSS version 13.0 
(SPSS Inc., Chicago, IL, USA). A χ2 test was used for cate-
gorical data, and an independent-samples t test was used for 
continuous parameters. A p value < 0.05 was considered 
statistically significant.
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Results
Two hundred pediatric patients were admitted with a di-
agnosis of gastroenteritis during the 6-month study pe-
riod. A total of 75 stool specimens were collected according 
to our design, and the sampling fraction was 37.5%. 
Among the 75 patients enrolled, 43 (57.3%) were male and 
32 (42.7%) were female. Twenty-eight patients (37.3%) had 
positive viral test results, and 12 (16.0%) had bacterial 
pathogens (Table 1). Three patients with mixed infections 
(norovirus plus Salmonella, norovirus plus Campylobacter, 
and rotavirus plus Shigella and Campylobacter) were ex-
cluded. Viruses were more common than bacteria, and 
norovirus was the leading pathogen (15 patients, 20.0%), 
followed by rotavirus (9 patients, 12.0%). Adenovirus and 
astrovirus were rare. Twelve norovirus cases were classi-
fied as genogroup II and the other three as genogroup I. 
Twelve patients (16.0%) had bacteria isolated from their 
stools. Seven (9.3%) contained Salmonella and five (6.7%) 
contained Campylobacter. No patients had positive blood 
culture results.
Most of the patients infected were under 2 years of age 
(22/39; 56.4%). There was no significant difference in the 
age distribution between patients with norovirus and 
rotavirus gastroenteritis (independent t test; p = 0.573) 
(Table 2).
Generally, the patients with norovirus gastroenteritis 
had milder symptoms than those with other infections. 
When compared with rotavirus infections, the norovirus 
infected patients had a lower percentage of fever (6/15 
vs. 9/9; p = 0.003), vomiting (3/15 vs. 6/9; p = 0.022), and 
shorter hospital stays (3.33 vs. 6.67 days; p = 0.006). Lower 
leukocyte counts and CRP levels were also noted, but 
Table 1. Pathogens of pediatric gastroenteritis patients 
(n = 75)a
Pathogen Number of patient
Virus 28 (37.3)
  Norovirus 15 (20.0)
  Rotavirus 9 (12.0)
  Adenovirus 3 (4.0)
  Astrovirus 1 (1.3)
Bacteria 12 (16.0)
  Salmonella spp. 7 (9.3)
  Campylobacter 5 (6.7)
Total 40 (53.3)
aData presented as n (%).
Table 2. Age distribution of pediatric gastroenteritis patients with different pathogensa
Parameters Norovirus (n = 15) Rotavirus (n = 9) Adenovirus (n = 3) Bacteria (n = 12) pb
Age (mo) 20 (1.5–90) 48 (2–84) 13 (12–20) 43 (9–96)
Mean age (mo) 37.6 ± 27.9 31.2 ± 24.0 15.0 ± 4.4 44.8 ± 32.2
Age distribution (mo)
 < 6 1 (6.7) 1 (11.1) – –
 6–24 7 (46.7) 4 (44.4) 3 (100) 6 (50.0)
 25–60 4 (26.7) 3 (33.3) – 2 (16.7)
 > 60 3 (20.0) 1 (11.1) – 4 (33.3)
Fever 6 (40.0) 9 (100) 2 (66.7) 11 (91.7) 0.003
Vomiting 3 (20.0) 6 (66.7) 2 (66.7) 3 (25.0) 0.022
Bloody mucoid stool 3 (20.0) 3 (33.3) 1 (33.3) 6 (50.0) 0.465
Hospital stay (d) 3.33 ± 1.50  6.67 ± 3.87 5.67 ± 2.08 5.58 ± 2.07 0.006
WBC (109/L) 9.027 ± 3.369 11.400 ± 4.800 16.667 ± 4.336 8.358 ± 2.309 0.168
CRP (mg/dL) 3.43 ± 2.99 5.12 ± 7.96 3.21 ± 3.84 4.09 ± 3.77 0.464
aData presented as median (range), mean ± standard deviation, or n (%); bcomparison between norovirus and rotavirus. WBC = White blood 
cell; CRP = C-reactive protein.
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the differences were not statistically significant. There 
were no deaths or serious complications in this series.
Discussion
Rotavirus remains the most prevalent viral pathogen in 
Taiwan according to several studies.2,3,5,13 Surprisingly, 
the prevalence of norovirus is greater than that of rotavirus 
in our study. Table 3 compares the prevalence of norovi-
rus reported by various investigators in Taiwan, Thailand 
and Japan. Our findings are similar to levels reported 
in other studies such as those by Veeravigrom et al in 
Thailand (22.7%),14 and Colomba et al in Italy (18.6%).15 
Chen et al reported the prevalence of norovirus to be as 
high as 29.3%, but half of the patients had mixed infections,3 
so the prevalence of an isolated norovirus infection was 
only 14.6%. We excluded mixed infections from our study. 
A survey in 1975 showed that 24% of Taiwanese children 
between 6–12 years old were positive for anti-Norwalk 
antibody.16 The prevalence of norovirus has been shown 
to change over time, and in different areas.5,10 Our study 
only represents the prevalence in pediatric hospitalized 
patients in the Taipei between late 2004 and early 2005. 
Nonetheless, it shows the important role of norovirus in 
pediatric gastroenteritis.
There are several genogroups of norovirus. Genogroups 
I and II are the most common in human gastroenteritis, 
although this may vary in different areas, years, seasons, 
and outbreaks.17,18 In this study, genogroup II was the 
predominant type, as was reported in another study done 
in Northern Taiwan during a similar period to our study; 
that series had a similar norovirus prevanence of 21.9%.4 
However, another study performed one year earlier in 
Northern Taiwan showed the prevalence of norovirus to 
be low (11.7%), and genogroup I was the dominant type.17 
The predominant genogroup in Osaka, Japan, during five 
winters (1996–2000) was genogroup II.18
The commercial enzyme-linked immunoassay (EIA) 
kit used for norovirus detection in this study, IDEIA NLV, 
contains several strains: genogroup I (Desert Shield, Norwalk, 
Southampton, Chiba), and genogroup II (Camberwell, three 
different Toronto/Mexico strains, Snowy Mountain, two 
different Hawaiian strains, and three Japanese isolates). 
The sensitivity and specificity of our kit was 55.5% 
and 98.3%, respectively.21 The diagnostic EIA method has 
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promising specificity, but unsatisfactory sensitivity, which 
may result in a lower detection rate. Some new strains 
have been noted in other outbreaks of norovirus gastro-
enteritis but they are, as yet, undetectable by these 
commercial EIA kits. Electron microscopy and reverse 
transcription-polymerase chain reaction are regarded as 
the diagnostic gold standards, but their clinical applica-
tions are relatively limited. The EIA method is more suit-
able for preliminary screening.22
Generally speaking, the severity of clinical manifesta-
tions of norovirus infection is relatively milder than other 
infections,4,23 as also shown in our data. The most common 
symptoms are fever, vomiting and diarrhea. Severe norovi-
rus infections may occur in infants, elders, or immuno-
compromised patients. Benign seizures have also been noted 
in patients with norovirus infections.24 No seizures, or 
other complications, developed in our study population.
Norovirus may be the major non-bacterial pathogen 
in outbreaks of gastroenteritis,19,25 and both children 
and adults are susceptible,9 and re-infection may occur.26 
Because the severity of the clinical symptoms is milder than 
for other bacterial- and rotavirus-mediated types of en-
teritis, subclinical infection is easily neglected. There fore, 
outbreaks follow. Over the period of our study, there was 
no cluster of infection noted in our study population. The 
spread of norovirus is rapid, and the main transmission 
pathway is via contaminated food and person-to-person 
contact.19 Early detection reminds us of the importance 
of decontamination measures, rather than the unneces-
sary use of antibiotics. In our study, we saw no evidence of 
a cluster of infections.
Both rotavirus and norovirus are common in cold sea-
sons, and norovirus usually hits its peak earlier.2,3,27 Our 
study covered the period between late fall, winter, and early 
spring, and rotavirus is considered to be the most preva-
lent virus in these seasons. Therefore, the higher prevalence 
of norovirus relative to rotavirus indicates a real disease 
burden of norovirus.
There are several limitations of our study. Our study 
was conducted in only one institution, and only sampled 
over a 6-month period. Since norovirus infection tends to 
be mild, and the serious gastroenteritis patients tends to 
be handled by the specialists within gastroenterology or 
infectious diseases, the high prevalence of norovirus 
infection may have been underestimated.
Rotavirus vaccines were not available in Taiwan dur-
ing the study period. Since rotavirus vaccines are used in 
Taiwan now, the prevalence of norovirus gastroenteritis 
may increase in the future.28
In conclusion, norovirus was determined to be the 
most common viral pathogen in Taipei between winter 
2004 and spring 2005, in children hospitalized with gas-
troenteritis. The emergence of norovirus infections in 
Taipei demands the awareness and attention of clinicians 
worldwide.
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